Literature DB >> 20150977

Potential of phage-displayed peptide library technology to identify functional targeting peptides.

Lauren Rh Krumpe1, Toshiyuki Mori.   

Abstract

Combinatorial peptide library technology is a valuable resource for drug discovery and development. Several peptide drugs developed through phage-displayed peptide library technology are presently in clinical trials and the authors envision that phage-displayed peptide library technology will assist in the discovery and development of many more. This review attempts to compile and summarize recent literature on targeting peptides developed through peptide library technology, with special emphasis on novel peptides with targeting capacity evaluated in vivo.

Keywords:  library; peptide; phage display; targeting

Year:  2007        PMID: 20150977      PMCID: PMC2818987          DOI: 10.1517/17460441.2.4.525

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN: 1746-0441            Impact factor:   6.098


  116 in total

1.  Isolation of multiple cell-binding ligands from different phage displayed-peptide libraries.

Authors:  Tsukasa Oyama; Irene T Rombel; Kausar N Samli; Xin Zhou; Kathlynn C Brown
Journal:  Biosens Bioelectron       Date:  2006-01-18       Impact factor: 10.618

2.  T7 lytic phage-displayed peptide libraries exhibit less sequence bias than M13 filamentous phage-displayed peptide libraries.

Authors:  Lauren R H Krumpe; Andrew J Atkinson; Gary W Smythers; Andrea Kandel; Kathryn M Schumacher; James B McMahon; Lee Makowski; Toshiyuki Mori
Journal:  Proteomics       Date:  2006-08       Impact factor: 3.984

3.  A new type of synthetic peptide library for identifying ligand-binding activity.

Authors:  K S Lam; S E Salmon; E M Hersh; V J Hruby; W M Kazmierski; R J Knapp
Journal:  Nature       Date:  1991-11-07       Impact factor: 49.962

4.  Novel SRESPHP peptide mediates specific binding to primary medullary thyroid carcinoma after systemic injection.

Authors:  Miriam Böckmann; Gero Hilken; Anke Schmidt; Aaron N Cranston; Andrea Tannapfel; Matthias Drosten; Andreja Frilling; Bruce A J Ponder; Brigitte M Pützer
Journal:  Hum Gene Ther       Date:  2005-11       Impact factor: 5.695

5.  One bead, one chemical compound: use of the selectide process for anticancer drug discovery.

Authors:  S E Salmon; K S Lam; S Felder; H Yeoman; J Schlessinger; A Ullrich; V Krchnák; M Lebl
Journal:  Acta Oncol       Date:  1994       Impact factor: 4.089

6.  Neuroblastoma tumor cell-binding peptides identified through random peptide phage display.

Authors:  J Zhang; H Spring; M Schwab
Journal:  Cancer Lett       Date:  2001-10-10       Impact factor: 8.679

7.  Combinatorial chemistry identifies high-affinity peptidomimetics against alpha4beta1 integrin for in vivo tumor imaging.

Authors:  Li Peng; Ruiwu Liu; Jan Marik; Xiaobing Wang; Yoshikazu Takada; Kit S Lam
Journal:  Nat Chem Biol       Date:  2006-06-11       Impact factor: 15.040

8.  Phage display affords peptides that modulate beta-amyloid aggregation.

Authors:  Brendan P Orner; Lin Liu; Regina M Murphy; Laura L Kiessling
Journal:  J Am Chem Soc       Date:  2006-09-13       Impact factor: 15.419

9.  Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.

Authors:  Shinji Tanaka; Stephanie C Pero; Kenichi Taguchi; Mitsuo Shimada; Masaki Mori; David N Krag; Shigeki Arii
Journal:  J Natl Cancer Inst       Date:  2006-04-05       Impact factor: 13.506

10.  Discovery of high-affinity peptide binders to BLyS by phage display.

Authors:  Tony J Fleming; Meena Sachdeva; Marko Delic; James Beltzer; Charles R Wescott; Mary Devlin; Robert C Lander; Andrew E Nixon; Viktor Roschke; David M Hilbert; Daniel J Sexton
Journal:  J Mol Recognit       Date:  2005 Jan-Feb       Impact factor: 2.137

View more
  9 in total

Review 1.  Drugs derived from phage display: from candidate identification to clinical practice.

Authors:  Andrew E Nixon; Daniel J Sexton; Robert C Ladner
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

Review 2.  Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.

Authors:  Kathlynn C Brown
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

3.  Comparison of two peptide radiotracers for prostate carcinoma targeting.

Authors:  Bluma Linkowski Faintuch; Erica A Oliveira; Eutimio G F Nunez; Ana M Moro; P K Nanda; Charles J Smith
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

Review 4.  A Global Review on Short Peptides: Frontiers and Perspectives.

Authors:  Vasso Apostolopoulos; Joanna Bojarska; Tsun-Thai Chai; Sherif Elnagdy; Krzysztof Kaczmarek; John Matsoukas; Roger New; Keykavous Parang; Octavio Paredes Lopez; Hamideh Parhiz; Conrad O Perera; Monica Pickholz; Milan Remko; Michele Saviano; Mariusz Skwarczynski; Yefeng Tang; Wojciech M Wolf; Taku Yoshiya; Janusz Zabrocki; Piotr Zielenkiewicz; Maha AlKhazindar; Vanessa Barriga; Konstantinos Kelaidonis; Elham Mousavinezhad Sarasia; Istvan Toth
Journal:  Molecules       Date:  2021-01-15       Impact factor: 4.411

5.  Screening of Yeast Display Libraries of Enzymatically Treated Peptides to Discover Macrocyclic Peptide Ligands.

Authors:  John Bowen; John Schneible; Kaitlyn Bacon; Collin Labar; Stefano Menegatti; Balaji M Rao
Journal:  Int J Mol Sci       Date:  2021-02-05       Impact factor: 5.923

6.  Trinucleotide cassettes increase diversity of T7 phage-displayed peptide library.

Authors:  Lauren R H Krumpe; Kathryn M Schumacher; James B McMahon; Lee Makowski; Toshiyuki Mori
Journal:  BMC Biotechnol       Date:  2007-10-05       Impact factor: 2.563

Review 7.  Recent Advances Toward the Discovery of Drug-Like Peptides De novo.

Authors:  Michael Goldflam; Christopher G Ullman
Journal:  Front Chem       Date:  2015-12-18       Impact factor: 5.221

Review 8.  Selection platforms for directed evolution in synthetic biology.

Authors:  Pedro A G Tizei; Eszter Csibra; Leticia Torres; Vitor B Pinheiro
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

9.  Identification of folate receptor α (FRα) binding oligopeptides and their evaluation for targeted virotherapy applications.

Authors:  Sarah L Hulin-Curtis; James A Davies; Davor Nestić; Emily A Bates; Alexander T Baker; Tabitha G Cunliffe; Dragomira Majhen; John D Chester; Alan L Parker
Journal:  Cancer Gene Ther       Date:  2020-01-06       Impact factor: 5.987

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.